{"id":9260,"date":"2022-05-10T03:00:00","date_gmt":"2022-05-10T03:00:00","guid":{"rendered":"https:\/\/www.prnasia.com\/story\/archive\/3751011_AE51011_0"},"modified":"2022-05-10T03:00:00","modified_gmt":"2022-05-10T03:00:00","slug":"robert-wessman-led-aztiq-completes-500-million-transaction-in-an-alliance-with-innobic-to-create-an-international-pharma-powerhouse","status":"publish","type":"post","link":"https:\/\/transmediavictoria.net.au\/?p=9260","title":{"rendered":"Robert Wessman-led Aztiq completes $500 million transaction in an alliance with Innobic to create an international pharma powerhouse"},"content":{"rendered":"<table name=\"logo_release\" border=\"0\" cellspacing=\"10\" cellpadding=\"5\" align=\"right\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/1696676\/AZTIQ_Logo.jpg?p=medium600\" border=\"0\" alt title=\"logo\" hspace=\"0\" vspace=\"0\" width=\"118\"><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<ul type=\"disc\">\n<li><b>The Consortium<\/b> jointly, through <b>Aztiq II HoldCo<\/b>, has&nbsp;completed the acquisition of a 100% stake in Alvogen Emerging Markets Holdings Limited, <b>thereby becoming the leading shareholders in Lotus Pharmaceuticals and Adalvo<\/b><\/li>\n<li><b>R\u00f3bert Wessman,<\/b> Chairman and CEO of Alvogen and Founder of Aztiq Pharma Partners, will continue as Chairman of the board of Lotus and Adalvo.<\/li>\n<li>The Consortium&#8217;s collective industry experience, geographic reach, and commitment to sustainable development, creates <b>a unique alliance of investors and leaders<\/b>, with the financial strength to support the companies&#8217; continued development.<\/li>\n<\/ul>\n<p><span class=\"xn-location\">LONDON<\/span>, <span class=\"xn-chron\">May 10, 2022<\/span> \/PRNewswire\/ &#8212; Aztiq Pharma Partners (&#8220;Aztiq&#8221;), a private equity company led by Alvogen Founder and Chairman R\u00f3bert Wessman, and Innobic (<span class=\"xn-location\">Asia<\/span>) Company Limited (&#8220;Innobic&#8221;) have completed the acquisition of a 100% stake in Alvogen Emerging Market Holdings Limited (&#8220;AEMH&#8221;) from its existing shareholders in a <span class=\"xn-money\">$500 million<\/span> deal to form a Pharma powerhouse with resources, networks and reach across the globe.<\/p>\n<div id=\"prni_dvprnejpg3b79left\" dir=\"ltr\"> <a href=\"https:\/\/mma.prnasia.com\/media2\/1813464\/Aztiq_ceremony.jpg?p=medium600\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" id=\"prnejpg3b79left\" title=\"From the ceremony\" src=\"https:\/\/mma.prnasia.com\/media2\/1813464\/Aztiq_ceremony.jpg?p=medium600\" alt=\"From the ceremony\" align=\"middle\" border=\"0\"><\/a> <br \/><span>From the ceremony<\/span> <\/div>\n<p>With this deal, which is one of the largest pharma transactions in the world this year, the consortium becomes the leading shareholder in the global oncology pharmaceutical company Lotus Pharmaceuticals (&#8220;Lotus&#8221;, TWSE ticker: 1795), and the owner of 100% shares in Alvogen Malta Holding Ltd., the shareholder of a fast-growing global business to business (B2B) pharmaceutical company Adalvo.<\/p>\n<p>AEMH was previously owned by Alvogen Lux Holdings Sarl (&#8220;Alvogen&#8221;).&nbsp; Key shareholders in Alvogen include CVC Capital Partners and Temasek Holdings of <span class=\"xn-location\">Singapore<\/span>, as well as Aztiq. Alvogen will remain a leading shareholder in the generics pharmaceutical company Alvogen US, including specialty pharma company Almatica, as well as being the second largest shareholder in global biosimilar company Alvotech.<\/p>\n<p>The expertise that the members of the consortium bring is impressive: <span class=\"xn-person\">Robert Wessman<\/span> has successfully grown private equity firm Aztiq from a small local business to a regional contender. Innobic is owned by the largest conglomerate in <span class=\"xn-location\">Thailand<\/span>, PTT Group, and has built extensive commercial and business networks in the fast-growing ASEAN countries.<\/p>\n<p>Aztiq is led by <span class=\"xn-person\">Robert Wessman<\/span>, who will continue to serve as Chairman of the Board of Lotus and Adalvo.<\/p>\n<p>This unique market knowledge along with strong support from shareholders will provide Lotus and Adalvo with a competitive advantage in a thriving industry, enabling them to become global leaders in the pharma industry. Both companies have the shared goal of making high-quality medicines accessible to patients around the world and with the expertise and resources that will be readily available to them, this goal will be further accelerated. From oral oncology to research for innovation to over-the-counter products, together Lotus and Adalvo will pave the way for global access to first-class treatments and medication.<\/p>\n<p><b>R\u00f3bert<\/b><b>&nbsp;Wessman, Chairman and CEO of Alvogen and Founder of Aztiq, commented<\/b><b>: &#8220;<\/b><i>I am very proud to have witnessed the maturation of both Lotus and Adalvo<\/i><i>. <\/i><i>I would like to take this opportunity to thank the existing shareholders for their great support in transformation of both Lotus and Adalvo and at the same time I would like to welcome our new partner, as we look forward to carrying out the essential work of expanding access to medicines with the strong expertise which all parties bring<\/i><i>. <\/i><i>With the comprehensive geographic networks and solid market intelligence in ASEAN brought by PTT and Innobic, I believe that Lotus and Adalvo will have a compelling competitive advantage, which enables both Lotus and Adalvo to become global leaders in their sectors<\/i><i>.&#8221;<\/i><\/p>\n<p><b>Dr<\/b><b>. <\/b><b>Buranin Rattanasombat, Senior Executive Vice President, Innovation and New Ventures, PTT and Chairman of Innobic <\/b><b>(<\/b><b><span class=\"xn-location\">Asia<\/span><\/b><b>)<\/b><b>, commented<\/b><b>: <\/b><i>I am very pleased with the success of this transaction, remarking this step as the beginning of the next chapter for the collaboration<\/i><i>.<\/i><i>&nbsp;Innobic<\/i>&nbsp;<i>is committed to explore and develop transformative therapies that improve access for patients in the Region<\/i><i>. <\/i><i>This collaboration will strengthen and enhance Lotus<\/i><i>&#8216; <\/i><i>competitiveness and Adalvo pharma presence<\/i>&nbsp;<i>in ASEAN and globally<\/i>.&#8221;<\/p>\n<p><b>About Aztiq<\/b><\/p>\n<p><b>Aztiq is a long<\/b><b>&#8211;<\/b><b>term healthcare investor <\/b>led by Alvogen&#8217;s and Alvotech&#8217;s Founder and Chairman R\u00f3bert Wessman.&nbsp; Aztiq, whose key investment focus is on pharmaceutical assets, is currently a leading and co-leading shareholder and operator of the following pharmaceutical assets:<\/p>\n<p><b><i>Lotus <\/i><\/b><i>\u2013 <\/i><i>A leading global pharmaceutical company <\/i><i>(<\/i><i><a href=\"http:\/\/www.lotuspharm.com\/\" target=\"_blank\" rel=\"nofollow noopener\">www.lotuspharm.com<\/a><\/i><i>)<\/i><\/p>\n<p><b><i>Adalvo<\/i><\/b><i>&nbsp;\u2013 <\/i><i>Global B2B pharmaceutical company <\/i><i>(<\/i><i><a href=\"http:\/\/www.adalvo.com\/\" target=\"_blank\" rel=\"nofollow noopener\">www.adalvo.com<\/a><\/i><i>)<\/i><\/p>\n<p><b><i>Alvotech<\/i><\/b><i>&nbsp;\u2013 <\/i><i>A global biosimilar company <\/i><i>(<\/i><i><a href=\"http:\/\/www.alvotech.com\/\" target=\"_blank\" rel=\"nofollow noopener\">www.alvotech.com<\/a><\/i><i>)<\/i><\/p>\n<p><b><i>Alvogen US <\/i><\/b><b><i>\/ <\/i><\/b><b><i>Almatica<\/i><\/b><i>&nbsp;\u2013 <\/i><i>US generics <\/i><i>(<\/i><i>Gx<\/i><i>) <\/i><i>and Specialty Pharmaceutical company<\/i><i>.&nbsp; (<\/i><i><a href=\"http:\/\/www.alvogenus.com\/\" target=\"_blank\" rel=\"nofollow noopener\">www.alvogenus.com<\/a><\/i><i>&nbsp;\/ <\/i><i><a href=\"http:\/\/www.almatica.com\/\" target=\"_blank\" rel=\"nofollow noopener\">www.almatica.com<\/a><\/i><i>)<\/i><\/p>\n<p><b>Established in 2009, Aztiq was founded on the principle that everyone should have the right to medicine, regardless of their financial means<\/b>.&nbsp;<\/p>\n<p>R\u00f3bert Wessman, has led over 50 strategic acquisitions and partnerships and established operations in over 60 countries<b>. <\/b>Wessman, alongside his seasoned team in Aztiq, continues to successfully launch and scale both industry<b>&#8211;<\/b>leading generic pharmaceutical and biosimilar companies all over the world<b>.<\/b><\/p>\n<p><b>Media Enquiries<\/b><b>:<\/b><\/p>\n<p>L\u00e1ra \u00d3marsd\u00f3ttir&nbsp;<br \/>+354 659 9166 <br \/><a href=\"mailto:lara@aztiq.is\" target=\"_blank\" rel=\"nofollow noopener\">lara@aztiq.is<\/a>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.aztiq.com\/\" target=\"_blank\" rel=\"nofollow noopener\">https:\/\/www.aztiq.com\/<\/a>&nbsp;&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Consortium jointly, through Aztiq II HoldCo, has&nbsp;completed the acquisition of a 100% stake in Alvogen Emerging Markets Holdings Limited, thereby becoming the leading shareholders in Lotus Pharmaceuticals and Adalvo R\u00f3bert Wessman, Chairman and CEO of Alvogen and Founder of Aztiq Pharma Partners, will continue as Chairman of the board of Lotus and Adalvo. The [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":9261,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-9260","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Robert Wessman-led Aztiq completes $500 million transaction in an alliance with Innobic to create an international pharma powerhouse - My Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/transmediavictoria.net.au\/?p=9260\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Robert Wessman-led Aztiq completes $500 million transaction in an alliance with Innobic to create an international pharma powerhouse - My Blog\" \/>\n<meta property=\"og:description\" content=\"The Consortium jointly, through Aztiq II HoldCo, has&nbsp;completed the acquisition of a 100% stake in Alvogen Emerging Markets Holdings Limited, thereby becoming the leading shareholders in Lotus Pharmaceuticals and Adalvo R\u00f3bert Wessman, Chairman and CEO of Alvogen and Founder of Aztiq Pharma Partners, will continue as Chairman of the board of Lotus and Adalvo. The [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/transmediavictoria.net.au\/?p=9260\" \/>\n<meta property=\"og:site_name\" content=\"My Blog\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-10T03:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2022\/05\/robert-wessman-led-aztiq-completes-500-million-transaction-in-an-alliance-with-innobic-to-create-an-international-pharma-powerhouse.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"144\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin_tony\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin_tony\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=9260#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=9260\"},\"author\":{\"name\":\"admin_tony\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"headline\":\"Robert Wessman-led Aztiq completes $500 million transaction in an alliance with Innobic to create an international pharma powerhouse\",\"datePublished\":\"2022-05-10T03:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=9260\"},\"wordCount\":828,\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=9260#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/transmediavictoria.net.au\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/robert-wessman-led-aztiq-completes-500-million-transaction-in-an-alliance-with-innobic-to-create-an-international-pharma-powerhouse.jpg\",\"articleSection\":[\"Business News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=9260\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=9260\",\"name\":\"Robert Wessman-led Aztiq completes $500 million transaction in an alliance with Innobic to create an international pharma powerhouse - My Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=9260#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=9260#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/transmediavictoria.net.au\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/robert-wessman-led-aztiq-completes-500-million-transaction-in-an-alliance-with-innobic-to-create-an-international-pharma-powerhouse.jpg\",\"datePublished\":\"2022-05-10T03:00:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=9260#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=9260\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=9260#primaryimage\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/robert-wessman-led-aztiq-completes-500-million-transaction-in-an-alliance-with-innobic-to-create-an-international-pharma-powerhouse.jpg\",\"contentUrl\":\"https:\\\/\\\/transmediavictoria.net.au\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/robert-wessman-led-aztiq-completes-500-million-transaction-in-an-alliance-with-innobic-to-create-an-international-pharma-powerhouse.jpg\",\"width\":600,\"height\":144},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=9260#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Robert Wessman-led Aztiq completes $500 million transaction in an alliance with Innobic to create an international pharma powerhouse\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\",\"name\":\"My Blog\",\"description\":\"My WordPress Blog\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\",\"name\":\"admin_tony\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"caption\":\"admin_tony\"},\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?author=8\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Robert Wessman-led Aztiq completes $500 million transaction in an alliance with Innobic to create an international pharma powerhouse - My Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/transmediavictoria.net.au\/?p=9260","og_locale":"en_US","og_type":"article","og_title":"Robert Wessman-led Aztiq completes $500 million transaction in an alliance with Innobic to create an international pharma powerhouse - My Blog","og_description":"The Consortium jointly, through Aztiq II HoldCo, has&nbsp;completed the acquisition of a 100% stake in Alvogen Emerging Markets Holdings Limited, thereby becoming the leading shareholders in Lotus Pharmaceuticals and Adalvo R\u00f3bert Wessman, Chairman and CEO of Alvogen and Founder of Aztiq Pharma Partners, will continue as Chairman of the board of Lotus and Adalvo. The [&hellip;]","og_url":"https:\/\/transmediavictoria.net.au\/?p=9260","og_site_name":"My Blog","article_published_time":"2022-05-10T03:00:00+00:00","og_image":[{"width":600,"height":144,"url":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2022\/05\/robert-wessman-led-aztiq-completes-500-million-transaction-in-an-alliance-with-innobic-to-create-an-international-pharma-powerhouse.jpg","type":"image\/jpeg"}],"author":"admin_tony","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin_tony","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/transmediavictoria.net.au\/?p=9260#article","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/?p=9260"},"author":{"name":"admin_tony","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"headline":"Robert Wessman-led Aztiq completes $500 million transaction in an alliance with Innobic to create an international pharma powerhouse","datePublished":"2022-05-10T03:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=9260"},"wordCount":828,"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=9260#primaryimage"},"thumbnailUrl":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2022\/05\/robert-wessman-led-aztiq-completes-500-million-transaction-in-an-alliance-with-innobic-to-create-an-international-pharma-powerhouse.jpg","articleSection":["Business News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/transmediavictoria.net.au\/?p=9260","url":"https:\/\/transmediavictoria.net.au\/?p=9260","name":"Robert Wessman-led Aztiq completes $500 million transaction in an alliance with Innobic to create an international pharma powerhouse - My Blog","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/#website"},"primaryImageOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=9260#primaryimage"},"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=9260#primaryimage"},"thumbnailUrl":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2022\/05\/robert-wessman-led-aztiq-completes-500-million-transaction-in-an-alliance-with-innobic-to-create-an-international-pharma-powerhouse.jpg","datePublished":"2022-05-10T03:00:00+00:00","author":{"@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"breadcrumb":{"@id":"https:\/\/transmediavictoria.net.au\/?p=9260#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/transmediavictoria.net.au\/?p=9260"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/transmediavictoria.net.au\/?p=9260#primaryimage","url":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2022\/05\/robert-wessman-led-aztiq-completes-500-million-transaction-in-an-alliance-with-innobic-to-create-an-international-pharma-powerhouse.jpg","contentUrl":"https:\/\/transmediavictoria.net.au\/wp-content\/uploads\/2022\/05\/robert-wessman-led-aztiq-completes-500-million-transaction-in-an-alliance-with-innobic-to-create-an-international-pharma-powerhouse.jpg","width":600,"height":144},{"@type":"BreadcrumbList","@id":"https:\/\/transmediavictoria.net.au\/?p=9260#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/transmediavictoria.net.au\/"},{"@type":"ListItem","position":2,"name":"Robert Wessman-led Aztiq completes $500 million transaction in an alliance with Innobic to create an international pharma powerhouse"}]},{"@type":"WebSite","@id":"https:\/\/transmediavictoria.net.au\/#website","url":"https:\/\/transmediavictoria.net.au\/","name":"My Blog","description":"My WordPress Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/transmediavictoria.net.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7","name":"admin_tony","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","caption":"admin_tony"},"url":"https:\/\/transmediavictoria.net.au\/?author=8"}]}},"_links":{"self":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/9260","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=9260"}],"version-history":[{"count":0,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/9260\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/media\/9261"}],"wp:attachment":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=9260"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=9260"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=9260"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}